首页> 外文期刊>Retina >Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion.
【24h】

Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion.

机译:玻璃体切除术和内部限制膜剥离对黄斑水肿继发于视网膜中央静脉阻塞和半膜静脉阻塞的长期影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: The purpose of this study was to evaluate the long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion (CRVO) and hemiretinal vein occlusion (HRVO). METHODS: Best-corrected visual acuity, central foveal thickness by optical coherence tomography, and fluorescein angiography were evaluated retrospectively in 20 patients (20 eyes). The mean follow-up time was 61.2 months. Pars plana vitrectomy and internal limiting membrane peeling using indocyanine green staining were performed in all patients. RESULTS: Preoperative mean central foveal thickness of all 20 eyes decreased significantly by 6 months, and this reduction was maintained until 60 months. The mean central foveal thickness of the group with perfused type CRVO, ischemic type CRVO, and HRVO at 6 months significantly decreased from the preoperative value, and the significant reduction was maintained until 60 months. Best-corrected visual acuity of the perfused CRVO and HRVO groups tended to improve in contrast to the ischemic CRVO group postoperatively. Best-corrected visual acuity of the perfused CRVO group at 24 months or later was significantly improved from preoperative best-corrected visual acuity. CONCLUSION: Pars plana vitrectomy with internal limiting membrane peeling in eyes with macular edema secondary to CRVO and HRVO produces an anatomical improvement, which persists up to 5 years, and a best-corrected visual acuity improvement, at least in perfused CRVO and HRVO.
机译:目的:本研究的目的是评估玻璃体切除术和内部限制膜剥离对继发于中央视网膜静脉阻塞(CRVO)和半视网膜静脉阻塞(HRVO)的黄斑水肿的长期效果。方法:对20例患者(20只眼)进行回顾性评估,以最佳校正的视力,光学相干断层扫描和荧光素血管造影对中央凹中央厚度进行评估。平均随访时间为61.2个月。所有患者均进行了pars平板玻璃体切除术和使用吲哚花青绿染色的内部限制膜剥离。结果:所有20只眼的术前平均中央凹厚度均在6个月前显着降低,并且这种降低一直维持到60个月。灌注型CRVO,缺血型CRVO和HRVO组在6个月时的平均中央凹厚度较术前值显着降低,并且显着降低直至60个月。与术后缺血性CRVO组相比,灌注CRVO和HRVO组的最佳矫正视力趋于提高。与术前最佳矫正视力相比,CRVO灌注组在24个月或更晚时的最佳矫正视力得到了显着改善。结论:对于继发于CRVO和HRVO的黄斑水肿的眼睛,内视镜玻璃体切除术具有内部限制膜剥离,至少在灌注CRVO和HRVO中,这种解剖学改善可以持续长达5年,并且具有最佳矫正视力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号